Good science behind hepatitis C virus antiviral drug development: necessary but not sufficient

Hepatology. 2007 Nov;46(5):1317-8. doi: 10.1002/hep.22053.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Drug Design
  • Drug Evaluation* / economics
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Toll-Like Receptor 9 / agonists

Substances

  • Antiviral Agents
  • Toll-Like Receptor 9